GNMSF vs AAPL: Which Stock is Better?
Side-by-side comparison of Genmab A/S and Apple Inc in 2026
GNMSF
Genmab A/S
$330.37
AAPL
Apple Inc
$246.86
Key Metrics Comparison
| Metric | GNMSF | AAPL | Winner |
|---|---|---|---|
| Market Cap | $20.35B | $3.66T | AAPL |
| P/E Ratio | 14.47 | 33.11 | GNMSF |
| EPS (TTM) | $22.83 | $7.45 | GNMSF |
| Revenue Growth | 0.2% | 0.1% | GNMSF |
| Gross Margin | 94.4% | 46.9% | GNMSF |
Analyze GNMSF
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GNMSF or AAPL a better investment?
Comparing GNMSF and AAPL: Genmab A/S has a market cap of $20.35B while Apple Inc has $3.66T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GNMSF and AAPL?
GNMSF (Genmab A/S) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GNMSF or AAPL?
Based on P/E ratios, GNMSF trades at a lower multiple (14.5x vs 33.1x).
Which is growing faster: GNMSF or AAPL?
GNMSF has higher revenue growth at 0.2% vs 0.1% for AAPL.
Which company is more profitable: GNMSF or AAPL?
Genmab A/S (GNMSF) has higher gross margins at 94.4% compared to 46.9% for AAPL.
Which is the larger company: GNMSF or AAPL?
Apple Inc (AAPL) is larger with a market cap of $3.66T compared to $20.35B for GNMSF.
Should I buy GNMSF or AAPL in 2026?
Both GNMSF and AAPL have investment merit. GNMSF trades at $330.37 while AAPL trades at $246.86. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GNMSF and AAPL stock?
Key differences: Market Cap ($20.35B vs $3.66T), P/E Ratio (14.5x vs 33.1x), Revenue Growth (0.2% vs 0.1%), Gross Margin (94.4% vs 46.9%).